講演情報
[O36-2]BEYOND: a randomised controlled trial (RCT) comparing efficacy and safety of an individualised fixed daily dose of follitropin delta in a gonadotropin-releasing hormone (GnRH) agonist versus antagonist protocol during first ovarian stimulation cycle in participants undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI)
○Philippe Pinton1, Rita Lobo1, Terje Soerdal2, Erling Ekerhovd3, Ben Cohlen4, Eleonora Porcu5, Michael Schenk6, Yoel Shufaro7 8, Jesper Smeenk9, Moritz B Suerdieck10, Anja Pinborg11 (1.Global Research & Medical, Ferring Pharmaceuticals, 2.Medicus AS, 3.Fertility Department Telemark Hospital, 4.Zwolle, Isala Fertility Center, 5.Infertility and IVF Unit, University of Bologna, 6.Das Kinderwunsch Institut, 7.Infertility and IVF, Beilinson Hospital, Rabin Medical Center, 8.Obstetrics & Gynecology, Faculty of Medicine, Tel-Aviv University, 9.Elisabeth Twee Steden Ziekenhuis, 10.Gyn-A.R.T. AG, 11.Fertility Department Rigshospitalet, Copenhagen University Hospital)